Drug Reaction With Eosinophilia and Systemic Symptoms
JAMA Dermatology · 01.03.2023 · 159 (3) · 348
DOI: 10.1001/jamadermatol.2022.4519 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.03.2023. Verfasst von Matthew S Krantz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Drug Hypersensitivity Syndrome, Eosinophilia. Die Arbeit wurde bisher 13-mal zitiert (Crossref).
Abstract (Originalsprache)
This Patient Page describes the symptoms, diagnosis, and treatment of drug reaction with eosinophilia and systemic symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Zitieren
APA
Krantz, M. S., & Phillips, E. J. (2023). Drug Reaction With Eosinophilia and Systemic Symptoms. JAMA Dermatology, 159(3), 348. https://doi.org/10.1001/jamadermatol.2022.4519
Vancouver
Krantz MS, Phillips EJ. Drug Reaction With Eosinophilia and Systemic Symptoms. JAMA Dermatology. 2023;159(3):348. doi:10.1001/jamadermatol.2022.4519
BibTeX
@article{Krantz2023,
author = {Krantz, Matthew S and Phillips, Elizabeth J},
title = {Drug Reaction With Eosinophilia and Systemic Symptoms},
journal = {JAMA Dermatology},
year = {2023},
volume = {159},
number = {3},
pages = {348},
doi = {10.1001/jamadermatol.2022.4519}
}
EUVIMED